Overview of herbal drugs: Regulatory perspective with special emphasis on global market
Clicks: 2
ID: 311502
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #228 of 254 articles by views in Yemen Journal of Medicine
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 254 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The market for herbal pharmaceuticals has grown significantly due to the growing demand for herbal medications worldwide, which is fueled by its perceived safety and natural source. However, regional differences in the regulatory frameworks governing these items provide difficulties for industry participants and impede the growth of the global market. This research offers a thorough analysis of the regulatory environment around herbal medications, looking at laws in important markets such as China, India, the US, and the EU. It draws attention to the intricate regulatory approval process and the necessity of international harmonization of safety, efficacy, and quality standards. Product quality and customer trust are frequently affected by differences in these regions' classification, licensing, and post-market surveillance regulations. The paper also discusses how new international regulatory initiatives, like the WHO's Traditional Medicine Strategy, are affecting the global standardization of herbal medication approval procedures. The paper also examines market trends, pointing to a growing demand for herbal treatments for the prevention of illness and the treatment of chronic conditions. Notwithstanding the strong market expansion, issues including product adulteration, a lack of therapeutic data, and restricted intellectual property rights still exist, calling for calculated regulatory changes to maintain consumer safety and market legitimacy. In addition to highlighting the significance of regulatory convergence, this report offers stakeholders practical advice on how to better manage the global herbal medication industry.
| Reference Key |
2026overview
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Pankaj Ramdas Khuspe*, Phade Swapnil, Inamdar Prajakta, Kakade Sakshi, Ingale Vaishnavi, Magar Srushti, Thavare Aishwarya |
| Journal | Yemen Journal of Medicine |
| Year | 2024 |
| DOI |
10.18231/j.yjom.2024.022
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.